Tennessee · 114th Regular Session (2025-2026) · Bill
SB 2549: Opioids - As enacted, adds that a healthcare provider who subcontracts through the contracted healthcare vendor with the department of correction may prescribe a buprenorphine product for the treatment of opioid use disorder if other certain listed criteria are met. - Amends TCA Title 53 and Title 63.
Enacted Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SB 2549 is a bill introduced in the Tennessee Senate on February 2, 2026. According to its official title, it concerns: Opioids - As enacted, adds that a healthcare provider who subcontracts through the contracted healthcare vendor with the department of correction may prescribe a buprenorphine product for the treatment of opioid use disorder if other certain listed criteria are met. - Amends TCA Title 53 and Title 63. Primary sponsor: Reeves. Most recent recorded action (April 13, 2026): Pub. Ch. 677.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Reeves | Primary sponsor | Not applicable (committee) | — | — |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Pub. Ch. 677
- Effective date(s) 04/07/2026
- Signed by Governor.
- Transmitted to Governor for action.
- Signed by H. Speaker
- Signed by Senate Speaker
- Enrolled and ready for signatures
- Subst. for comp. HB.
- Passed H., Ayes 82, Nays 0, PNV 2
- Rcvd. from S., held on H. desk.
- Passed Senate, Ayes 30, Nays 1
- Engrossed; ready for transmission to House
Showing 12 most recent of 21 actions. Full history